A Trial to Measure the Safety and Efficacy of Vyndaqel Treatment in Patients With Transthyretin Amyloid Cardiomyopathy

Open-Label Safety and Efficacy Evaluation of FX-1006A in Patients With V122I or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

Category & Conditions:
Cardiovasular Diseases and Conditions
Medicine:
VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B3461026
Open Plain Language Summary Result:Click here